Skip to main content

Select Drug Profiles

Perspectives
Personalized Medicine: Are We There Yet?
David B. Nash, MD, MBA
Read More
Perspectives
Rewarding Innovation in Drug Development
Emily Saadi, Greg White, MPP
Read More
Original Research
Evaluation of Dabigatran for Appropriateness of Use and Bleeding Events in a Community Hospital Setting
Anastasia L Armbruster, PharmD, BCPS, Katie S Buehler, PharmD, BCPS, Sun H Min, PharmD, Margaret Riley, PharmD, Michael W Daly, PharmD, MSCI, BCPS
Stakeholder Perspective
Accurate Prescribing Key to Safe Use of Anticoagulants in Patients with Nonvalvular Atrial Fibrillation
by Raymond L. Singer, MD, MMM, CPE
Read More
Original Research
Patient Preferences and Treatment Adherence Among Women Diagnosed with Metastatic Breast Cancer
Marco daCosta DiBonaventura, PhD, Ronda Copher, PhD, Enrique Basurto, MSc, Claudio Faria, PharmD, MPH, Rose Lorenzo, BA
Stakeholder Perspective
Predicting Behavior: It’s a Matter of Preference
by Albert Tzeel, MD, MHSA, CPE, FAAPL
Read More
Conference Highlights AMCP
Health Economics Outcomes and Payers’ Perspectives
Read More
Diagnosis and Management of Polycythemia Vera
Read More
Dermatology
Novel Rosacea Compound, Ivermectin Cream, Offers Unique Mechanism of Action
Caroline Helwick
Read More
Dermatology
Ivermectin Cream Will Contribute Much to the Treatment of Patients with Rosacea: Interview with Dr Zoe Draelos
Caroline Helwick
Read More
Perspectives
A Different Kind of Merger
David B. Nash, MD, MBA
Read More
Original Research
Cardiovascular Events and Safety Outcomes Associated with Azithromycin Therapy: A Meta-Analysis of Randomized Controlled Trials
Ziyad S. Almalki, BPharm, PhD candidate, Jeff Jianfei Guo, BPharm, PhD
Stakeholder Perspective
Cardiovascular Safety of Azithromycin Therapy: Revisiting the Evidence
by Raymond L. Singer, MD, MMM, CPE
Read More
Page 144 of 244
Results 1431 - 1440 of 2438